United Therapeutics Corp. (UTHR) PT Lowered to $103 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
United Therapeutics Corp. (UTHR) PT Lowered to $107 at Ladenburg Thalmann
May 3, 2018 6:56 AM EDTLadenburg Thalmann lowered its price target on United Therapeutics Corp. (NASDAQ: UTHR) to $107.00 (from $120.00) while maintaining a Neutral rating.
... MoreUnited Therapeutics Corp. (UTHR) PT Lowered to $95 at Barclays
May 3, 2018 3:55 AM EDTBarclays lowered its price target on United Therapeutics Corp. (NASDAQ: UTHR) to $95.00 (from $105.00) while maintaining a Underweight rating.
... MoreJMP Securities Downgrades SteadyMed (STDY) to Market Perform Following Acquisition
May 1, 2018 3:25 AM EDTJMP Securities downgraded SteadyMed (NASDAQ: STDY) from Market Outperform to Market Perform.
Analyst Donald Ellis steps to the sideline following the recent acquisition by United Therapeutics (NASDAQ: UTHR). The analyst is not expecting a competing offer to... More
